AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer
Journal of Imaging · 28.08.2024 · 10 (9) · 211
DOI: 10.3390/jimaging10090211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Imaging, online erschienen am 28.08.2024. Verfasst von Mio Adachi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Tokyo Medical and Dental University Hospital, Tokyo 113-8510, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Although several studies have been conducted on artificial intelligence (AI) use in mammography (MG), there is still a paucity of research on the diagnosis of metachronous bilateral breast cancer (BC), which is typically more challenging to diagnose. This study aimed to determine whether AI could enhance BC detection, achieving earlier or more accurate diagnoses than radiologists in cases of metachronous contralateral BC. We included patients who underwent unilateral BC surgery and subsequently developed contralateral BC. This retrospective study evaluated the AI-supported MG diagnostic system called FxMammo™. We evaluated the capability of FxMammo™ (FathomX Pte Ltd., Singapore) to diagnose BC more accurately or earlier than radiologists’ assessments. This evaluation was supplemented by reviewing MG readings made by radiologists. Out of 1101 patients who underwent surgery, 10 who had initially undergone a partial mastectomy and later developed contralateral BC were analyzed. The AI system identified malignancies in six cases (60%), while radiologists identified five cases (50%). Notably, two cases (20%) were diagnosed solely by the AI system. Additionally, for these cases, the AI system had identified malignancies a year before the conventional diagnosis. This study highlights the AI system’s effectiveness in diagnosing metachronous contralateral BC via MG. In some cases, the AI system consistently diagnosed cancer earlier than radiological assessments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Tokyo Medical and Dental University Hospital, Tokyo 113-8510, Japan.
- Department of Diagnostic Radiology, Tokyo Medical and Dental University Hospital, Tokyo 113-8510, Japan.
- Ohtsuka Breast Care Clinic, Tokyo 121-0813, Japan.
- Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore 119074, Singapore.
- Department of Surgery, National University Hospital, National University Health System, Singapore 119074, Singapore.
- Institute of Data Science, National University of Singapore, Singapore 117597, Singapore.
ORCID-Profile: Mio Adachi, Toshiyuki Ishiba, Emi Yamaga, Feng Mengling, Kazunori Kubota
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Adachi, M., Fujioka, T., Ishiba, T., Nara, M., Maruya, S., Hayashi, K., Kumaki, Y., Yamaga, E., Katsuta, L., Hao, D., Hartman, M., Mengling, F., Oda, G., Kubota, K., & Tateishi, U. (2024). AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer. Journal of Imaging, 10(9), 211. https://doi.org/10.3390/jimaging10090211
Vancouver
Adachi M, Fujioka T, Ishiba T, Nara M, Maruya S, Hayashi K, et al. AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer. Journal of Imaging. 2024;10(9):211. doi:10.3390/jimaging10090211
BibTeX
@article{Adachi2024,
author = {Adachi, Mio and Fujioka, Tomoyuki and Ishiba, Toshiyuki and Nara, Miyako and Maruya, Sakiko and Hayashi, Kumiko and Kumaki, Yuichi and Yamaga, Emi and Katsuta, Leona and Hao, Du and Hartman, Mikael and Mengling, Feng and Oda, Goshi and Kubota, Kazunori and Tateishi, Ukihide},
title = {AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer},
journal = {Journal of Imaging},
year = {2024},
volume = {10},
number = {9},
pages = {211},
doi = {10.3390/jimaging10090211}
}
EUVIMED